The iShares Morningstar Mid-Cap Growth ETF (IMCG) seeks to track the Morningstar US Mid Cap Broad Growth Index, which measures mid-capitalization U.S. companies exhibiting above-average growth characteristics. This growth-focused equity ETF targets companies with strong earnings growth, revenue expansion, and forward-looking growth metrics within the mid-cap market segment.

How It Works

IMCG uses a passively managed, market-capitalization-weighted approach that mirrors companies selected by Morningstar's growth screening methodology. The underlying index identifies mid-cap stocks with high historical earnings growth, strong sales growth, and positive earnings revisions from analysts. Holdings are weighted by market value and rebalanced quarterly to maintain growth characteristics. The fund typically holds 200-400 mid-cap growth companies, providing concentrated exposure to this specific market segment.

Key Features

  • Targets pure growth characteristics using Morningstar's proprietary screening for earnings growth, sales expansion, and analyst revisions
  • Focuses exclusively on mid-cap sweet spot, capturing companies between large-cap stability and small-cap volatility
  • Established 2007 track record with 0.00% expense ratio, though AUM data suggests limited current investor adoption

Risks

  • This ETF can lose value when growth stocks fall out of favor, potentially declining 40-50% during growth-to-value rotations like 2022
  • Mid-cap concentration risk means higher volatility than broad market ETFs, with potential for 20-30% swings during market stress
  • Growth premium risk exists when investors shift toward value stocks, causing sustained underperformance during economic uncertainty periods

Who Should Own This

Best suited as a satellite holding (10-20% of equity allocation) for aggressive investors with 5+ year time horizons seeking mid-cap growth exposure. High risk tolerance required due to growth stock volatility and mid-cap concentration. Appropriate for investors wanting to overweight the growth factor within their mid-cap allocation or complement large-cap core holdings.